FDA





COVID-19 Vaccine Development

A tuned and collaborative program to coronavirus infection 2019 (COVID-19) vaccine research and development (R&D) is highly required for a prosperous consequence, according to a…



Heart Failure Medication Approved

The FDA has awarded a further implication for dapagliflozin (Farxiga, AstraZeneca Pharmaceuticals), heart failure medication, the first sodium-glucose co-transporter 2 (SGLT2) inhibitor to be allowed…




Anti-Schizophrenia Drug Approved by The FDA

FDA has confirmed lumateperone tosylate (Caplyta™, Intra-Cellular Therapies) anti-schizophrenia drug for the therapy of schizophrenia in grown-up sufferers. Lumateperone is an atypical antipsychotic. The precise…